- Thursday, August 17, 2023
7:00 AM – 5:00 PM
Welcome
7:00 AM – 5:00 PM
Registration Hours
Location:Essex Foyer
8:00 AM – 8:15 AM
Welcome
8:00 AM – 8:15 AM
WelcomeLocation:Essex Center/SouthCo-Chair: – Weill Cornell Medicine/New York Presbyterian
John P. Leonard, MD – Weill Cornell Medicine/New York Presbyterian ### 692254###Co-Chair###Senior Associate Dean for Innovation and Initiatives; Chair (Interim), Weill Department of Medicine; Richard T. Silver Distinguished Professor of Hematology and Medical Oncology###Weill Cornell Medicine/New York Presbyterian###Co-Chair: – Weill Cornell Medicine/New York Presbyterian
### 8:15 AM – 8:50 AM
1 - Session 1: Choosing among Options for the Initial Therapy of Aggressive Lymphoma
8:15 AM – 8:50 AM
Session 1: Choosing among Options for the Initial Therapy of Aggressive LymphomaLocation:Essex Center/SouthPresenter: – Weill Cornell Medicine/New York Presbyterian
John P. Leonard, MD – Weill Cornell Medicine/New York Presbyterian ### 692254###Presenter###Senior Associate Dean for Innovation and Initiatives; Chair (Interim), Weill Department of Medicine; Richard T. Silver Distinguished Professor of Hematology and Medical Oncology###Weill Cornell Medicine/New York Presbyterian###Presenter: – Weill Cornell Medicine/New York Presbyterian
### 8:50 AM – 9:00 AM
Live Q&A
8:50 AM – 9:00 AM
Live Q&ALocation:Essex Center/SouthSpeaker: – Weill Cornell Medicine/New York Presbyterian
John P. Leonard, MD – Weill Cornell Medicine/New York Presbyterian ### 692254###Speaker###Senior Associate Dean for Innovation and Initiatives; Chair (Interim), Weill Department of Medicine; Richard T. Silver Distinguished Professor of Hematology and Medical Oncology###Weill Cornell Medicine/New York Presbyterian###Speaker: – Weill Cornell Medicine/New York Presbyterian
### 9:00 AM – 9:45 AM
2 - Session 2: Case Discussions
9:00 AM – 9:45 AM
Session 2: Case DiscussionsLocation:Essex Center/SouthModerator: – Rutgers University
Panelist: – Chao Family Comprehensive Cancer Center, University of California, Irvine
Panelist: – University of Rochester
Andrew Evens, DO, MBA, MSc (he/him/his) – Rutgers University ### 1649997###Moderator###Associate Vice Chancellor, RBHS, and Associate Director, Rutgers CINJ###Rutgers University###Moderator: – Rutgers University
### he/him/his @@@ Elizabeth A. Brem, MD (she/her/hers) – Chao Family Comprehensive Cancer Center, University of California, Irvine ### 694303###Panelist###Clinical Associate Professor###Chao Family Comprehensive Cancer Center, University of California, Irvine###Panelist: – Chao Family Comprehensive Cancer Center, University of California, Irvine
### she/her/hers @@@ Carla Casulo, MD (she/her/hers) – University of Rochester ### 824439###Panelist###Associate Professor of Medicine, Hematology/Oncology###University of Rochester###Panelist: – University of Rochester
### she/her/hers9:45 AM – 9:50 AM
Exhibit Hall
9:50 AM – 10:50 AM
Non-CME Innvoation Theater
9:50 AM – 10:50 AM
Non-CME Innovation Theater - Sponsored by Lilly
Location:Essex North
10:50 AM – 11:00 AM
Exhibit Hall
10:50 AM – 11:00 AM
Exhibit Hall Break
11:00 AM – 11:35 AM
3 - Session 3: How Do We Choose among non-CAR-T Options for Patients with Recurrent Aggressive Lymphoma
11:00 AM – 11:35 AM
Session 3: How Do We Choose among non-CAR-T Options for Patients with Recurrent Aggressive LymphomaLocation:Essex Center/SouthPresenter: – Alpert Medical School of Brown University
Adam J. Olszewski, MD – Alpert Medical School of Brown University ### 1630531###Presenter###Associate Professor of Medicine###Alpert Medical School of Brown University###Presenter: – Alpert Medical School of Brown University
### 11:35 AM – 11:45 AM
Live Q&A
11:35 AM – 11:45 AM
Live Q&ALocation:Essex Center/SouthModerator: – Weill Cornell Medicine/New York Presbyterian
Speaker: – Alpert Medical School of Brown University
John P. Leonard, MD – Weill Cornell Medicine/New York Presbyterian ### 692254###Moderator###Senior Associate Dean for Innovation and Initiatives; Chair (Interim), Weill Department of Medicine; Richard T. Silver Distinguished Professor of Hematology and Medical Oncology###Weill Cornell Medicine/New York Presbyterian###Moderator: – Weill Cornell Medicine/New York Presbyterian
### @@@ Adam J. Olszewski, MD – Alpert Medical School of Brown University ### 1630531###Speaker###Associate Professor of Medicine###Alpert Medical School of Brown University###Speaker: – Alpert Medical School of Brown University
### 11:45 AM – 12:20 PM
4 - Session 4: Managing Relapsed/Refractory Follicular Lymphoma: Novel Therapeutic Strategies Across Treatment Lines
11:45 AM – 12:20 PM
Session 4: Managing Relapsed/Refractory Follicular Lymphoma: Novel Therapeutic Strategies Across Treatment Lines Location:Essex Center/SouthPresenter: – University of Rochester
Carla Casulo, MD (she/her/hers) – University of Rochester ### 824439###Presenter###Associate Professor of Medicine, Hematology/Oncology###University of Rochester###Presenter: – University of Rochester
### she/her/hers12:20 PM – 12:30 PM
Live Q&A
12:20 PM – 12:30 PM
Live Q&ALocation:Essex Center/SouthModerator: – Weill Cornell Medicine/New York Presbyterian
Speaker: – University of Rochester
John P. Leonard, MD – Weill Cornell Medicine/New York Presbyterian ### 692254###Moderator###Senior Associate Dean for Innovation and Initiatives; Chair (Interim), Weill Department of Medicine; Richard T. Silver Distinguished Professor of Hematology and Medical Oncology###Weill Cornell Medicine/New York Presbyterian###Moderator: – Weill Cornell Medicine/New York Presbyterian
### @@@ Carla Casulo, MD (she/her/hers) – University of Rochester ### 824439###Speaker###Associate Professor of Medicine, Hematology/Oncology###University of Rochester###Speaker: – University of Rochester
### she/her/hers12:30 PM – 12:35 PM
Exhibit Hall
12:30 PM – 12:35 PM
Break
12:35 PM – 1:35 PM
Non-CME Innvoation Theater
12:35 PM – 1:35 PM
Non-CME Innovation Theater - Sponsored by AstraZeneca
Location:Essex North
1:35 PM – 2:10 PM
5 - Session 5: Antibody Drug Conjugates – Where and When to Use Them in Hodgkin Lymphoma
1:35 PM – 2:10 PM
Session 5: Antibody Drug Conjugates – Where and When to Use Them in Hodgkin LymphomaLocation:Essex Center/SouthPresenter: – Rutgers University
Andrew Evens, DO, MBA, MSc (he/him/his) – Rutgers University ### 1649997###Presenter###Associate Vice Chancellor, RBHS, and Associate Director, Rutgers CINJ###Rutgers University###Presenter: – Rutgers University
### he/him/his2:10 PM – 2:20 PM
Live Q&A
2:10 PM – 2:20 PM
Live Q&ALocation:Essex Center/SouthModerator: – Weill Cornell Medicine/New York Presbyterian
Speaker: – Rutgers University
John P. Leonard, MD – Weill Cornell Medicine/New York Presbyterian ### 692254###Moderator###Senior Associate Dean for Innovation and Initiatives; Chair (Interim), Weill Department of Medicine; Richard T. Silver Distinguished Professor of Hematology and Medical Oncology###Weill Cornell Medicine/New York Presbyterian###Moderator: – Weill Cornell Medicine/New York Presbyterian
### @@@ Andrew Evens, DO, MBA, MSc (he/him/his) – Rutgers University ### 1649997###Speaker###Associate Vice Chancellor, RBHS, and Associate Director, Rutgers CINJ###Rutgers University###Speaker: – Rutgers University
### he/him/his2:20 PM – 2:55 PM
6 - Session 6: Targeted Treatment for Mantle Cell Lymphoma: Reimagining First-Line Therapy
2:20 PM – 2:55 PM
Session 6: Targeted Treatment for Mantle Cell Lymphoma: Reimagining First-Line TherapyLocation:Essex Center/SouthPresenter: – Dana-Farber Cancer Institute
Ann LaCasce, MD – Dana-Farber Cancer Institute ### 1364718###Presenter###Associate Professor of Medicine###Dana-Farber Cancer Institute###Presenter: – Dana-Farber Cancer Institute
### 2:55 PM – 3:05 PM
Live Q&A
2:55 PM – 3:05 PM
Live Q&ALocation:Essex Center/SouthModerator: – Weill Cornell Medicine/New York Presbyterian
Speaker: – Dana-Farber Cancer Institute
John P. Leonard, MD – Weill Cornell Medicine/New York Presbyterian ### 692254###Moderator###Senior Associate Dean for Innovation and Initiatives; Chair (Interim), Weill Department of Medicine; Richard T. Silver Distinguished Professor of Hematology and Medical Oncology###Weill Cornell Medicine/New York Presbyterian###Moderator: – Weill Cornell Medicine/New York Presbyterian
### @@@ Ann LaCasce, MD – Dana-Farber Cancer Institute ### 1364718###Speaker###Associate Professor of Medicine###Dana-Farber Cancer Institute###Speaker: – Dana-Farber Cancer Institute
### 3:05 PM – 3:35 PM
Exhibit Hall
3:05 PM – 3:35 PM
Exhibit Hall Break
3:35 PM – 4:10 PM
Session 7: Where I use CAR-T therapy in Patients in Recurrent Lymphoma?
3:35 PM – 4:10 PM
Session 7: Where I use CAR-T therapy in Patients in Recurrent Lymphoma?Location:Essex Center/SouthPresenter: – Dana-Farber Cancer Institute, Harvard Medical School
Caron A. Jacobson, MD, MMSc – Dana-Farber Cancer Institute, Harvard Medical School ### 692255###Presenter###Associate Professor of Medicine###Dana-Farber Cancer Institute, Harvard Medical School###Presenter: – Dana-Farber Cancer Institute, Harvard Medical School
### 4:10 PM – 4:20 PM
Live Q&A
4:10 PM – 4:20 PM
Live Q&ALocation:Essex Center/SouthModerator: – Weill Cornell Medicine/New York Presbyterian
Speaker: – Dana-Farber Cancer Institute, Harvard Medical School
John P. Leonard, MD – Weill Cornell Medicine/New York Presbyterian ### 692254###Moderator###Senior Associate Dean for Innovation and Initiatives; Chair (Interim), Weill Department of Medicine; Richard T. Silver Distinguished Professor of Hematology and Medical Oncology###Weill Cornell Medicine/New York Presbyterian###Moderator: – Weill Cornell Medicine/New York Presbyterian
### @@@ Caron A. Jacobson, MD, MMSc – Dana-Farber Cancer Institute, Harvard Medical School ### 692255###Speaker###Associate Professor of Medicine###Dana-Farber Cancer Institute, Harvard Medical School###Speaker: – Dana-Farber Cancer Institute, Harvard Medical School
### 4:20 PM – 4:37 PM
7 - Session 8: Debate - CNS Prophylaxis in Aggressive Lymphoma - Aggressive
4:20 PM – 4:37 PM
Session 8: Debate - CNS Prophylaxis in Aggressive Lymphoma - AggressiveLocation:Essex Center/SouthPresenter: – Alpert Medical School of Brown University
Adam J. Olszewski, MD – Alpert Medical School of Brown University ### 1630531###Presenter###Associate Professor of Medicine###Alpert Medical School of Brown University###Presenter: – Alpert Medical School of Brown University
### 4:37 PM – 4:55 PM
7 - Session 8: Debate - CNS Prophylaxis in Aggressive Lymphoma - Futile
4:37 PM – 4:55 PM
Session 8: Debate - CNS Prophylaxis in Aggressive Lymphoma - FutileLocation:Essex Center/SouthPresenter: – Chao Family Comprehensive Cancer Center, University of California, Irvine
Elizabeth A. Brem, MD (she/her/hers) – Chao Family Comprehensive Cancer Center, University of California, Irvine ### 694303###Presenter###Clinical Associate Professor###Chao Family Comprehensive Cancer Center, University of California, Irvine###Presenter: – Chao Family Comprehensive Cancer Center, University of California, Irvine
### she/her/hers4:55 PM – 5:05 PM
7 - Session 8: Debate - CNS Prophylaxis in Aggressive Lymphoma
4:55 PM – 5:05 PM
Session 8: Debate - CNS Prophylaxis in Aggressive Lymphoma - DiscussionLocation:Essex Center/SouthModerator: – Weill Cornell Medicine/New York Presbyterian
Panelist: – Chao Family Comprehensive Cancer Center, University of California, Irvine
Panelist: – Alpert Medical School of Brown University
John P. Leonard, MD – Weill Cornell Medicine/New York Presbyterian ### 692254###Moderator###Senior Associate Dean for Innovation and Initiatives; Chair (Interim), Weill Department of Medicine; Richard T. Silver Distinguished Professor of Hematology and Medical Oncology###Weill Cornell Medicine/New York Presbyterian###Moderator: – Weill Cornell Medicine/New York Presbyterian
### @@@ Elizabeth A. Brem, MD (she/her/hers) – Chao Family Comprehensive Cancer Center, University of California, Irvine ### 694303###Panelist###Clinical Associate Professor###Chao Family Comprehensive Cancer Center, University of California, Irvine###Panelist: – Chao Family Comprehensive Cancer Center, University of California, Irvine
### she/her/hers @@@ Adam J. Olszewski, MD – Alpert Medical School of Brown University ### 1630531###Panelist###Associate Professor of Medicine###Alpert Medical School of Brown University###Panelist: – Alpert Medical School of Brown University
### - Friday, August 18, 2023
7:30 AM – 5:00 PM
Welcome
7:30 AM – 5:00 PM
Registration Hours
Location:Essex Foyer
8:00 AM – 8:15 AM
Welcome
8:00 AM – 8:15 AM
WelcomeLocation:Essex Center/SouthCo-Chair: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
Jessica K. Altman, MD – Robert H. Lurie Comprehensive Cancer Center; Northwestern University ### 944495###Co-Chair###Professor of Medicine###Robert H. Lurie Comprehensive Cancer Center; Northwestern University###Co-Chair: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
### 8:15 AM – 8:30 AM
8 - Session 9: Updates in ND FLT3 AML
8:15 AM – 8:30 AM
Session 9: Updates in ND FLT3 AMLLocation:Essex Center/SouthPresenter: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
Jessica K. Altman, MD – Robert H. Lurie Comprehensive Cancer Center; Northwestern University ### 944495###Presenter###Professor of Medicine###Robert H. Lurie Comprehensive Cancer Center; Northwestern University###Presenter: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
### 8:30 AM – 9:00 AM
Live Q&A
8:30 AM – 9:00 AM
Case Discussions in AMLLocation:Essex Center/SouthModerator: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
Panelist: – Harvard Medical School; Center for Leukemia, Mass General Cancer Center
Panelist: – University of Rochester Medical Center, Wilmot Cancer Institute
Jessica K. Altman, MD – Robert H. Lurie Comprehensive Cancer Center; Northwestern University ### 944495###Moderator###Professor of Medicine###Robert H. Lurie Comprehensive Cancer Center; Northwestern University###Moderator: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
### @@@ Amir T. Fathi, MD – Harvard Medical School; Center for Leukemia, Mass General Cancer Center ### 1533702###Panelist###Associate Professor of Medicine; Harvard Medical School, Program Director, Leukemia, MGH###Harvard Medical School; Center for Leukemia, Mass General Cancer Center###Panelist: – Harvard Medical School; Center for Leukemia, Mass General Cancer Center
### @@@ Kristen O'Dwyer, MD – University of Rochester Medical Center, Wilmot Cancer Institute ### 1544763###Panelist###Associate Professor of Medicine and Oncology###University of Rochester Medical Center, Wilmot Cancer Institute###Panelist: – University of Rochester Medical Center, Wilmot Cancer Institute
### 9:00 AM – 9:35 AM
9 - Session 10: First Line Treatment of CLL/SLL with Bruton 's Tyrosine Kinase Inhibitors: Seeking Lasting Results
9:00 AM – 9:35 AM
Session 10: First Line Treatment of CLL/SLL with Bruton 's Tyrosine Kinase Inhibitors: Seeking Lasting ResultsLocation:Essex Center/SouthPresenter: – Weill Cornell Medicine
John N. Allan, MD – Weill Cornell Medicine ### 748659###Presenter###Associate Professor of Clinical Medicine###Weill Cornell Medicine###Presenter: – Weill Cornell Medicine
### 9:35 AM – 9:45 AM
Live Q&A
9:35 AM – 9:45 AM
Live Q&ALocation:Essex Center/SouthModerator: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
Speaker: – Weill Cornell Medicine
Jessica K. Altman, MD – Robert H. Lurie Comprehensive Cancer Center; Northwestern University ### 944495###Moderator###Professor of Medicine###Robert H. Lurie Comprehensive Cancer Center; Northwestern University###Moderator: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
### @@@ John N. Allan, MD – Weill Cornell Medicine ### 748659###Speaker###Associate Professor of Clinical Medicine###Weill Cornell Medicine###Speaker: – Weill Cornell Medicine
### 9:45 AM – 9:50 AM
Exhibit Hall
9:50 AM – 10:50 AM
Non-CME Innvoation Theater
9:50 AM – 10:50 AM
Non-CME Innovation Theater - Sponsored by Rigel
Location:Essex North
10:50 AM – 11:00 AM
Exhibit Hall
10:50 AM – 11:00 AM
Exhibit Hall Break
11:00 AM – 11:35 AM
10 - Session 11: What Are the Latest Strategies for Relapsed CLL and What Is on the Horizon?
11:00 AM – 11:35 AM
Session 11: What Are the Latest Strategies for Relapsed CLL and What Is on the Horizon? Location:Essex Center/SouthPresenter: – Dana-Farber Cancer Institute / Harvard Medical School
Matthew S. Davids, MD, MMSc – Dana-Farber Cancer Institute / Harvard Medical School ### 748660###Presenter###Director of Clinical Research, Division of Lymphoma / Associate Professor of Medicine###Dana-Farber Cancer Institute / Harvard Medical School###Presenter: – Dana-Farber Cancer Institute / Harvard Medical School
###
11:35 AM – 11:45 AM
Live Q&A
11:35 AM – 11:45 AM
Live Q&ALocation:Essex Center/SouthSpeaker: – Dana-Farber Cancer Institute / Harvard Medical School
Matthew S. Davids, MD, MMSc – Dana-Farber Cancer Institute / Harvard Medical School ### 748660###Speaker###Director of Clinical Research, Division of Lymphoma / Associate Professor of Medicine###Dana-Farber Cancer Institute / Harvard Medical School###Speaker: – Dana-Farber Cancer Institute / Harvard Medical School
### 11:45 AM – 12:20 PM
11 - Session 12: Orphan Hematologic Malignancies --Systemic Mastocytosis and Myeloid-Lymphoid Neoplasms: Classification, Diagnosis, Genetics and Targeted Therapeutic Options
11:45 AM – 12:20 PM
Session 12: Orphan Hematologic Malignancies --Systemic Mastocytosis and Myeloid-Lymphoid Neoplasms: Classification, Diagnosis, Genetics and Targeted Therapeutic OptionsLocation:Essex Center/SouthPresenter: – Dana-Farber Cancer Institute; Harvard Medical School
Daniel J. DeAngelo, MD, PhD – Dana-Farber Cancer Institute; Harvard Medical School ### 692263###Presenter###Chief of the Division of Leukemia; Professor of Medicine###Dana-Farber Cancer Institute; Harvard Medical School###Presenter: – Dana-Farber Cancer Institute; Harvard Medical School
### 12:20 PM – 12:30 PM
Live Q&A
12:20 PM – 12:30 PM
Live Q&ALocation:Essex Center/SouthModerator: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
Speaker: – Dana-Farber Cancer Institute; Harvard Medical School
Jessica K. Altman, MD – Robert H. Lurie Comprehensive Cancer Center; Northwestern University ### 944495###Moderator###Professor of Medicine###Robert H. Lurie Comprehensive Cancer Center; Northwestern University###Moderator: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
### @@@ Daniel J. DeAngelo, MD, PhD – Dana-Farber Cancer Institute; Harvard Medical School ### 692263###Speaker###Chief of the Division of Leukemia; Professor of Medicine###Dana-Farber Cancer Institute; Harvard Medical School###Speaker: – Dana-Farber Cancer Institute; Harvard Medical School
### 12:30 PM – 12:35 PM
Exhibit Hall
12:30 PM – 12:35 PM
Break
12:35 PM – 1:35 PM
Lunch
1:35 PM – 2:10 PM
12 - Session 13: Effective Risk Stratification and Expert Treatment Selection Advice for Patients with Myelodysplastic Syndromes
1:35 PM – 2:10 PM
Session 13: Effective Risk Stratification and Expert Treatment Selection Advice for Patients with Myelodysplastic SyndromesLocation:Essex Center/SouthPresenter: – Yale New Haven Health
Amer M. Zeidan, MBBS, MHS (he/him/his) – Yale New Haven Health ### 703522###Presenter###Associate Professor###Yale New Haven Health###Presenter: – Yale New Haven Health
### he/him/his2:10 PM – 2:20 PM
Live Q&A
2:10 PM – 2:20 PM
Live Q&ALocation:Essex Center/SouthModerator: – University of Rochester Medical Center, Wilmot Cancer Institute
Speaker: – Yale New Haven Health
Kristen O'Dwyer, MD – University of Rochester Medical Center, Wilmot Cancer Institute ### 1544763###Moderator###Associate Professor of Medicine and Oncology###University of Rochester Medical Center, Wilmot Cancer Institute###Moderator: – University of Rochester Medical Center, Wilmot Cancer Institute
### @@@ Amer M. Zeidan, MBBS, MHS (he/him/his) – Yale New Haven Health ### 703522###Speaker###Associate Professor###Yale New Haven Health###Speaker: – Yale New Haven Health
### he/him/his2:20 PM – 3:05 PM
13 - Session 14: What Is New in Relapsed AML With a Focus on Menin and IDH Inhibitors?
2:20 PM – 2:55 PM
Session 14: What Is New in Relapsed AML With a Focus on Menin and IDH Inhibitors?Location:Essex Center/SouthPresenter: – Harvard Medical School; Center for Leukemia, Mass General Cancer Center
Amir T. Fathi, MD – Harvard Medical School; Center for Leukemia, Mass General Cancer Center ### 1533702###Presenter###Associate Professor of Medicine; Harvard Medical School, Program Director, Leukemia, MGH###Harvard Medical School; Center for Leukemia, Mass General Cancer Center###Presenter: – Harvard Medical School; Center for Leukemia, Mass General Cancer Center
### 2:55 PM – 3:05 PM
Live Q&A
2:55 PM – 3:05 PM
Live Q&ALocation:Essex Center/SouthModerator: – University of Rochester Medical Center, Wilmot Cancer Institute
Speaker: – Harvard Medical School; Center for Leukemia, Mass General Cancer Center
Kristen O'Dwyer, MD – University of Rochester Medical Center, Wilmot Cancer Institute ### 1544763###Moderator###Associate Professor of Medicine and Oncology###University of Rochester Medical Center, Wilmot Cancer Institute###Moderator: – University of Rochester Medical Center, Wilmot Cancer Institute
### @@@ Amir T. Fathi, MD – Harvard Medical School; Center for Leukemia, Mass General Cancer Center ### 1533702###Speaker###Associate Professor of Medicine; Harvard Medical School, Program Director, Leukemia, MGH###Harvard Medical School; Center for Leukemia, Mass General Cancer Center###Speaker: – Harvard Medical School; Center for Leukemia, Mass General Cancer Center
### 3:05 PM – 3:35 PM
Exhibit Hall
3:05 PM – 3:35 PM
Exhibit Hall Break
3:35 PM – 3:52 PM
14 - Session 15: Debate - MRD+ Patients with AML Should Proceed with HSCT - Yes
3:35 PM – 3:52 PM
Session 15: Debate - MRD+ Patients with AML Should Proceed with HSCT - YesLocation:Essex Center/SouthPresenter: – City of Hope
Andrew Artz, MD, MS – City of Hope ### 1649062###Presenter###Professor###City of Hope###Presenter: – City of Hope
### 3:52 PM – 4:10 PM
14 - Session 15: Debate - MRD+ Patients with AML Should Proceed with HSCT - No
3:52 PM – 4:10 PM
Session 15: Debate - MRD+ Patients with AML Should Proceed with HSCT - NoLocation:Essex Center/SouthPresenter: – Dana-Farber Cancer Institute, Harvard Medical School
Richard M. Stone, MD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School ### 972507###Presenter###Chief of Staff; Professor of Medicine###Dana-Farber Cancer Institute, Harvard Medical School###Presenter: – Dana-Farber Cancer Institute, Harvard Medical School
### he/him/his4:10 PM – 4:20 PM
14 - Session 15: Debate - MRD+ Patients with AML Should Proceed with HSCT
4:10 PM – 4:20 PM
Session 15: Debate - MRD+ Patients with AML Should Proceed with HSCT - DiscussionLocation:Essex Center/SouthModerator: – University of Rochester Medical Center, Wilmot Cancer Institute
Panelist: – City of Hope
Panelist: – Dana-Farber Cancer Institute, Harvard Medical School
Kristen O'Dwyer, MD – University of Rochester Medical Center, Wilmot Cancer Institute ### 1544763###Moderator###Associate Professor of Medicine and Oncology###University of Rochester Medical Center, Wilmot Cancer Institute###Moderator: – University of Rochester Medical Center, Wilmot Cancer Institute
### @@@ Andrew Artz, MD, MS – City of Hope ### 1649062###Panelist###Professor###City of Hope###Panelist: – City of Hope
### @@@ Richard M. Stone, MD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School ### 972507###Panelist###Chief of Staff; Professor of Medicine###Dana-Farber Cancer Institute, Harvard Medical School###Panelist: – Dana-Farber Cancer Institute, Harvard Medical School
### he/him/his4:20 PM – 4:55 PM
13 - Session 16: Risk Stratification in ALL and Approach to Treatment
4:20 PM – 4:55 PM
Session 16: Risk Stratification in ALL and Approach to TreatmentLocation:Essex Center/SouthPresenter: – University of Rochester Medical Center, Wilmot Cancer Institute
Kristen O'Dwyer, MD – University of Rochester Medical Center, Wilmot Cancer Institute ### 1544763###Presenter###Associate Professor of Medicine and Oncology###University of Rochester Medical Center, Wilmot Cancer Institute###Presenter: – University of Rochester Medical Center, Wilmot Cancer Institute
### 4:55 PM – 5:05 PM
Live Q&A
4:55 PM – 5:05 PM
Live Q&ALocation:Essex Center/SouthSpeaker: – University of Rochester Medical Center, Wilmot Cancer Institute
Panelist: – City of Hope
Kristen O'Dwyer, MD – University of Rochester Medical Center, Wilmot Cancer Institute ### 1544763###Speaker###Associate Professor of Medicine and Oncology###University of Rochester Medical Center, Wilmot Cancer Institute###Speaker: – University of Rochester Medical Center, Wilmot Cancer Institute
### @@@ Andrew Artz, MD, MS – City of Hope ### 1649062###Panelist###Professor###City of Hope###Panelist: – City of Hope
### 5:05 PM – 5:45 PM
13 - Special Session: Exciting Advances in Myelofibrosis
5:05 PM – 5:45 PM
Special Session: Exciting Advances in MyelofibrosisLocation:Essex Center/SouthSpeaker: – Massachusetts General Hospital
Gabriela S. Hobbs, MD (she/her/hers) – Massachusetts General Hospital ### 854690###Speaker###Clinical Director, Leukemia Service.###Massachusetts General Hospital###Speaker: – Massachusetts General Hospital
### she/her/hers- Saturday, August 19, 2023
7:30 AM – 5:00 PM
Welcome
7:30 AM – 5:00 PM
Registration Hours
Location:Essex Foyer
8:00 AM – 8:15 AM
Welcome
8:00 AM – 8:15 AM
WelcomeLocation:Essex Center/SouthCo-Chair: – Massachusetts General Hospital Cancer Center
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Co-Chair###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Co-Chair: – Massachusetts General Hospital Cancer Center
### 8:15 AM – 8:32 PM
15 - Session 17: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy? - Yes
8:15 AM – 8:32 PM
Session 17: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy? - YesLocation:Essex Center/SouthPresenter: – City of Hope Comprehensive Cancer Center
Amrita Y. Krishnan, MD, FACP – City of Hope Comprehensive Cancer Center ### 902613###Presenter###Director of Judy and Bernard Briskin Center for Multiple Myeloma###City of Hope Comprehensive Cancer Center###Presenter: – City of Hope Comprehensive Cancer Center
### 8:32 AM – 8:49 AM
15 - Session 17: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy? - No
8:32 AM – 8:49 AM
Session 17: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy? - NoLocation:Essex Center/SouthPresenter: – Sylvester Comprehensive Cancer Center, University of Miami
C. Ola Landgren, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami ### 1364707###Presenter###Professor of Medicine; Chief of Myeloma Division; Director of Sylvester Myeloma Research Institute; Leader of Experimental Therapeutics Program###Sylvester Comprehensive Cancer Center, University of Miami###Presenter: – Sylvester Comprehensive Cancer Center, University of Miami
### 8:49 AM – 9:00 AM
15 - Session 17: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy?
8:49 AM – 9:00 AM
Session 17: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy? - DiscussionLocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Panelist: – City of Hope Comprehensive Cancer Center
Panelist: – Sylvester Comprehensive Cancer Center, University of Miami
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Amrita Y. Krishnan, MD, FACP – City of Hope Comprehensive Cancer Center ### 902613###Panelist###Director of Judy and Bernard Briskin Center for Multiple Myeloma###City of Hope Comprehensive Cancer Center###Panelist: – City of Hope Comprehensive Cancer Center
### @@@ C. Ola Landgren, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami ### 1364707###Panelist###Professor of Medicine; Chief of Myeloma Division; Director of Sylvester Myeloma Research Institute; Leader of Experimental Therapeutics Program###Sylvester Comprehensive Cancer Center, University of Miami###Panelist: – Sylvester Comprehensive Cancer Center, University of Miami
### 9:00 AM – 9:35 AM
16 - Session 18: Optimal Frontline Therapy of Myeloma
9:00 AM – 9:35 AM
Session 18: Optimal Frontline Therapy of MyelomaLocation:Essex Center/SouthPresenter: – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine
Peter M. Voorhees, MD – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine ### 903003###Presenter###Clinical Professor of Medicine###Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine###Presenter: – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine
### 9:35 AM – 9:45 AM
Live Q&A
9:35 AM – 9:45 AM
Live Q&ALocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Speaker: – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Peter M. Voorhees, MD – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine ### 903003###Speaker###Clinical Professor of Medicine###Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine###Speaker: – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine
### 9:45 AM – 9:50 AM
Exhibit Hall
9:50 AM – 10:50 AM
Non-CME Innvoation Theater
9:50 AM – 10:50 AM
Non-CME Innovation Theater - Sponsored by Genentech
Location:Essex North
10:50 AM – 11:00 AM
Exhibit Hall
10:50 AM – 11:00 AM
Exhibit Hall Break
11:00 AM – 11:35 AM
17 - Session 19: Optimizing Myeloma Therapies for Older and More Frail Patients
11:00 AM – 11:35 AM
Session 19: Optimizing Myeloma Therapies for Older and More Frail Patients Location:Essex Center/SouthPresenter: – Dana-Farber Cancer Institute
Irene Ghobrial, MD – Dana-Farber Cancer Institute ### 1000158###Presenter###Professor of Medicine###Dana-Farber Cancer Institute###Presenter: – Dana-Farber Cancer Institute
###
11:35 AM – 11:45 AM
Live Q&A
11:35 AM – 11:45 AM
Live Q&ALocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Speaker: – Dana-Farber Cancer Institute
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Irene Ghobrial, MD – Dana-Farber Cancer Institute ### 1000158###Speaker###Professor of Medicine###Dana-Farber Cancer Institute###Speaker: – Dana-Farber Cancer Institute
### 11:45 AM – 12:20 PM
20 - Session 20: Making Sense of the Choices in Relapsed Myeloma
11:45 AM – 12:20 PM
Session 20: Making Sense of the Choices in Relapsed MyelomaLocation:Essex Center/SouthPresenter: – Massachusetts General Hospital Cancer Center
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Presenter###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Presenter: – Massachusetts General Hospital Cancer Center
### 12:20 PM – 12:30 PM
Live Q&A
12:20 PM – 12:30 PM
Live Q&ALocation:Essex Center/SouthSpeaker: – Massachusetts General Hospital Cancer Center
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Speaker###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Speaker: – Massachusetts General Hospital Cancer Center
### 12:30 PM – 12:35 PM
Exhibit Hall
12:30 PM – 12:35 PM
Break
12:35 PM – 1:35 PM
Non-CME Innvoation Theater
12:35 PM – 1:35 PM
Non-CME Innovation Theater - Sponsored by Janssen
Location:Essex North
1:35 PM – 2:10 PM
18 - Session 21: Relapsed/ Refractory Multiple Myeloma: Novel and Cellular Therapies in 2023
1:35 PM – 2:10 PM
Session 21: Relapsed/ Refractory Multiple Myeloma: Novel and Cellular Therapies in 2023Location:Essex Center/SouthPresenter: – Dana-Farber Cancer Institute
Monique Hartley-Brown, MD, MMSc – Dana-Farber Cancer Institute ### 1983676###Presenter###Assistant Professor###Dana-Farber Cancer Institute###Presenter: – Dana-Farber Cancer Institute
### 2:10 PM – 2:20 PM
Live Q&A
2:10 PM – 2:20 PM
Live Q&ALocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Speaker: – Dana-Farber Cancer Institute
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Monique Hartley-Brown, MD, MMSc – Dana-Farber Cancer Institute ### 1983676###Speaker###Assistant Professor###Dana-Farber Cancer Institute###Speaker: – Dana-Farber Cancer Institute
### 2:20 PM – 3:05 PM
19 - Session 22: Special Panel - Future of Myeloma
2:20 PM – 3:05 PM
Session 22: Special Panel - Future of MyelomaLocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Panelist: – Dana-Farber Cancer Institute
Panelist: – City of Hope
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Monique Hartley-Brown, MD, MMSc – Dana-Farber Cancer Institute ### 1983676###Panelist###Assistant Professor###Dana-Farber Cancer Institute###Panelist: – Dana-Farber Cancer Institute
### @@@ Michael Rosenzweig, MD – City of Hope ### 1830638###Panelist###Associate Professor of Medicine###City of Hope###Panelist: – City of Hope
### 3:05 PM – 3:35 PM
Exhibit Hall
3:05 PM – 3:35 PM
Exhibit Hall Break
3:35 PM – 4:10 PM
21 - Session 23: How Do I Diagnose and Treat AL Amyloidosis?
3:35 PM – 4:10 PM
Session 23: How Do I Diagnose and Treat AL Amyloidosis?Location:Essex Center/SouthPresenter: – City of Hope
Michael Rosenzweig, MD – City of Hope ### 1830638###Presenter###Associate Professor of Medicine###City of Hope###Presenter: – City of Hope
### 4:10 PM – 4:20 PM
Live Q&A
4:10 PM – 4:20 PM
Live Q&ALocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Speaker: – City of Hope
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Michael Rosenzweig, MD – City of Hope ### 1830638###Speaker###Associate Professor of Medicine###City of Hope###Speaker: – City of Hope
### 4:20 PM – 4:55 PM
Session 24: Optimal Management of MGUS and Smoldering Myeloma
4:20 PM – 4:55 PM
Session 24: Optimal Management of MGUS and Smoldering MyelomaLocation:Essex Center/SouthPresenter: – H.Lee Moffitt Cancer Center
Melissa Alsina, MD – H.Lee Moffitt Cancer Center ### 1864650###Presenter###Head, Myeloma Section###H.Lee Moffitt Cancer Center###Presenter: – H.Lee Moffitt Cancer Center
### 4:55 PM – 5:05 PM
Live Q&A
4:55 PM – 5:05 PM
Live Q&ALocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Speaker: – H.Lee Moffitt Cancer Center
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Melissa Alsina, MD – H.Lee Moffitt Cancer Center ### 1864650###Speaker###Head, Myeloma Section###H.Lee Moffitt Cancer Center###Speaker: – H.Lee Moffitt Cancer Center
###
